[Skip to Content]
[Skip to Content Landing]
April 17, 1991

Monitoring for Side Effects of NSAIDs-Reply

Author Affiliations

California Medical Facility-Main Vacaville

California Medical Facility-Main Vacaville

JAMA. 1991;265(15):1951. doi:10.1001/jama.1991.03460150054017

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


In Reply.—  Dr Graham objects to my suggestion of "careful and serial" monitoring of liver functions, suggesting that this wording places an unnecessary burden on the prescribing physician and indeed may make him or her more liable to litigation.As part of my conclusion, I stated, "We would be well advised, then, to monitor liver functions (especially the transaminases) carefully and serially in any patient undergoing long-term NSAID therapy." I further recommended baseline liver profile studies in any individual suspected to be at risk for hepatic injury (as briefly outlined, alcohol or other drug abusers, those debilitated or immunocompromised, those testing positive for the human immunodeficiency virus or at risk for the acquired immunodeficiency virus, those with a history of foreign travel, those exposed to toxic industrial products or hepatitis, those receiving blood transfusions, or those with a "chronic pain" problem with attendant "overmedication," either "self" or iatrogenic.Dr Graham